Fresenius Medical Care AG & Co. KGaA (ETR:FME) Shares Cross Below 200 Day Moving Average of $68.61

Share on StockTwits

Shares of Fresenius Medical Care AG & Co. KGaA (ETR:FME) passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $68.61 and traded as low as $59.68. Fresenius Medical Care AG & Co. KGaA shares last traded at $60.84, with a volume of 439,196 shares changing hands.

Several brokerages have commented on FME. Berenberg Bank set a €89.95 ($104.59) price target on Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research report on Friday, July 26th. Kepler Capital Markets set a €80.00 ($93.02) price objective on Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a report on Thursday, May 2nd. Deutsche Bank set a €100.00 ($116.28) price objective on Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a report on Wednesday, July 31st. Credit Suisse Group set a €71.00 ($82.56) price objective on Fresenius Medical Care AG & Co. KGaA and gave the stock a “neutral” rating in a report on Thursday, August 1st. Finally, JPMorgan Chase & Co. set a €85.30 ($99.19) price objective on Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a report on Wednesday, July 31st. Seven research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of €81.19 ($94.41).

The company has a 50 day moving average of €65.93 and a 200 day moving average of €68.61. The company has a current ratio of 0.99, a quick ratio of 0.63 and a debt-to-equity ratio of 105.19. The firm has a market cap of $18.55 billion and a price-to-earnings ratio of 15.08.

About Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

See Also: What is the Gross Domestic Product (GDP)?

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.